Skip to main content
Jon Lykkegaard Andersen on Muck Rack

Jon Lykkegaard Andersen

As seen in: Future Medicine, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jon Lykkegaard

Contact Jon Lykkegaard, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis

|
By Jon Lykkegaard Andersen, Peter Meldgaard, Jakob Sidenius Johansen, Edyta Maria Urbanska
| Future Medicine Verified
Globally, lung cancer has a historic 5-year overall survival (OS) rate of 10–20% [1]; in Denmark 5-year survival is currently slightly less than 20% [2]. However, lung cancer survival is currently improving rapidly due to the advent of drugs that either target distinct molecular alterations driving tumorigenesis or activates the immune system to fight cancer [3].
Open in Who Shared Issue with article?
See all 1 articles